The ubiquitin-protein ligase Itch regulates p73 stability

被引:272
作者
Rossi, M
De Laurenzi, V
Munarriz, E
Green, DR
Liu, YC
Vousden, KH
Cesareni, G
Melino, G
机构
[1] Univ Leicester, Med Res Council, Toxicol Unit, Leicester LE1 9HN, Leics, England
[2] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[3] Univ Roma Tor Vergata, Biochem Lab, IDI IRCCS, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy
[4] La Jolla Inst Allergy & Immunol, San Diego, CA USA
[5] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
degradation; E3; ligase; p53; proteasome;
D O I
10.1038/sj.emboj.7600444
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p73, a member of the p53 family of transcription factors, is upregulated in response to DNA damage, inducing cell cycle arrest and apoptosis. Besides indications that this p73 response is post- transcriptional, little is known about the underlying molecular mechanisms of p73 protein degradation. Ubiquitination and proteasomal- dependent degradation of p53 are regulated by its transcriptional target MDM2. However, unlike p53, p73 binds to, but is not degraded by, MDM2. Here we describe the binding of p73 to Itch, a Hect ubiquitin - protein ligase. Itch selectively binds and ubiquitinates p73 but not p53; this results in the rapid proteasome- dependent degradation of p73. Upon DNA damage Itch itself is downregulated, allowing p73 protein levels to rise and thus interfere with p73 function. In conclusion, we have identified a key mechanism in the control of p73 protein levels both in normal as well as in stress conditions.
引用
收藏
页码:836 / 848
页数:13
相关论文
共 50 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] Mdm2 binds p73α without targeting degradation
    Bálint, E
    Bates, S
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (27) : 3923 - 3929
  • [3] Ubiquitin-dependent degradation of p73 is inhibited by PML
    Bernassola, F
    Salomoni, P
    Oberst, A
    Di Como, CJ
    Pagano, M
    Melino, G
    Pandolfi, PP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) : 1545 - 1557
  • [4] Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
    Casciano, I
    Mazzocco, K
    Boni, L
    Pagnan, G
    Banelli, B
    Allemanni, G
    Ponzoni, M
    Tonini, GP
    Romani, M
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (03) : 246 - 251
  • [5] Castagnoli L, 2001, COMB CHEM HIGH T SCR, V4, P121
  • [6] Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage
    Catani, MV
    Costanzo, A
    Savini, I
    Levrero, M
    De Laurenzi, V
    Wang, JYJ
    Melino, G
    Avigiliano, L
    [J]. BIOCHEMICAL JOURNAL, 2002, 364 : 441 - 447
  • [7] Cesareni G, 1999, COMB CHEM HIGH T SCR, V2, P1
  • [8] Induction of neuronal differentiation by p73 in a neuroblastoma cell line
    De Laurenzi, V
    Raschellá, G
    Barcaroli, D
    Annicchiarico-Petruzzelli, M
    Ranalli, M
    Catani, MV
    Tanno, B
    Costanzo, A
    Levrero, M
    Melino, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 15226 - 15231
  • [9] Additional complexity in p73:: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ
    De Laurenzi, V
    Catani, MV
    Terrinoni, A
    Corazzari, M
    Melino, G
    Costanzo, A
    Levrero, M
    Knight, RA
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) : 389 - 390
  • [10] Two new p73 splice variants, γ and δ, with different transcriptional activity
    De Laurenzi, V
    Costanzo, A
    Barcaroli, D
    Terrinoni, A
    Falco, M
    Annicchiarico-Petruzzeli, M
    Levrero, M
    Melino, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1763 - 1768